RAC 2.92% $1.94 race oncology ltd

Ann: Race Initiates FTO Directed Kidney Cancer Preclinical Study, page-14

  1. 1,313 Posts.
    lightbulb Created with Sketch. 270
    Far from minor, just shows how the average punter doesn't get it.

    "The results of this study will support Phase II human trials of Bisantrene in ccRCC, currently
    scheduled to begin in Australia in early 2022."
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.94
Change
0.055(2.92%)
Mkt cap ! $330.4M
Open High Low Value Volume
$1.89 $1.96 $1.85 $333.0K 174.5K

Buyers (Bids)

No. Vol. Price($)
1 3105 $1.94
 

Sellers (Offers)

Price($) Vol. No.
$1.95 7574 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.